New York - With expected advances in immunotherapy, the future is bright for nonsurgical treatment of nonmelanoma skin cancer, said John K. Geisse, M.D., at the American Academy of Dermatology Academy '04 here recently.
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Highlights from AAD 2023
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
New Technology Could Allow Us to Rethink Alopecia Scores
Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus
2 Clarke Drive Cranbury, NJ 08512